. Results of fitting of the kinetic data (A1, t1, y0), first-order rate constants (k), and half-lives (t 1/2 ). Product Peak 1 (RT 18.7 min) y = A1*exp(-x/t1) + y0 -29. a Parameter y0 was kept fixed at 0; b Parameter A1 was kept fixed at 97, which corresponds to the average percentage of the total area for the two isomers of rapamycin found in non-degraded samples; c The first six time points were used for fitting; For these data points, the sum area for the two isomers of rapamycin and two products accounted for >94% of the total area under the curve. 9 were obtained from a 13 C inverse-gated decoupled NMR experiment for rapamycin and from an additional gHMBC experiment with a smaller n J CH value for secorapamycin. Resonances corresponding to trans-and cis-rotamers were labeled with letters "t" and "c", respectively. For secorapamycin, the measurements were performed in the absence and in the presence of 0.025% trifluoroacetic acid (TFA); b Relative to the residual proton signal of THF-d8 assigned to 3.58 ppm; c Relative to the signal of THF-d8 assigned to 67.57 ppm; S 20 Figure S10 .
1 H-NMR spectrum of rapamycin in 1:1 THF-d 8 /D 2 O. Resonances corresponding to transand cis-rotamers were labeled with letters "T" and "C", respectively. S 21 Figure S11 .
1 H-NMR spectrum of secorapamycin in 1:1 THF-d 8 /D 2 O. Resonances corresponding to trans-and cis-rotamers were labeled with letters "T" and "C", respectively. S 22 Figure S12 .
1 H-NMR spectrum of secorapamycin in 1:1 THF-d 8 /D 2 O containing 0.025% trifluoroacetic acid. Resonances corresponding to trans-and cis-rotamers were labeled with letters "T" and "C", respectively.
